AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 281: L749-L761, 2001;
1040-0605/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Filippatos, G. S.
Right arrow Articles by Uhal, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Filippatos, G. S.
Right arrow Articles by Uhal, B. D.
Vol. 281, Issue 4, L749-L761, October 2001

INVITED REVIEW
Regulation of apoptosis by vasoactive peptides

Gerasimos S. Filippatos1, Nupur Gangopadhyay2, Omosalewa Lalude3, Narayanan Parameswaran2, Sami I. Said4,5, William Spielman2, and Bruce D. Uhal2

1 Second Division of Cardiology, Evangelismos General Hospital, GR-11526 Athens, Greece; 2 Department of Physiology, Michigan State University, East Lansing, Michigan 48824; 3 Division of Cardiology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio 44106; 4 Department of Medicine, University Medical Center, Stony Brook 11794; and 5 Veterans Affairs Medical Center, Northport, New York 11772

Although originally discovered because of their ability to affect hemodynamics, vasoactive peptides have been found to function in a variety of capacities including neurotransmission, endocrine functions, and the regulation of cell proliferation. A growing body of evidence describes the ability of vasoactive peptides to regulate cell death by apoptosis in either a positive or negative fashion depending on the peptide and the type of target cell. The available evidence to date is strongest for the peptides endothelin, angiotensin II, vasoactive intestinal peptide, atrial natriuretic peptide, and adrenomedullin. Each of these peptides is discussed, with specific regard to apoptosis, in terms of regulatory activity, target cell specificity, and potential role in pulmonary physiology.

programmed cell death; blood pressure; pulmonary pathophysiology; hypertension; lung fibrosis


This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
J. Penchalaneni, S. J. Wimalawansa, and C. Yallampalli
Adrenomedullin Antagonist Treatment During Early Gestation in Rats Causes Fetoplacental Growth Restriction Through Apoptosis
Biol Reprod, November 1, 2004; 71(5): 1475 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Wang, W. Sun, and X. Wang
Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1582 - H1589.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S P D'Souza and G F Baxter
B Type natriuretic peptide: a good omen in myocardial ischaemia?
Heart, July 1, 2003; 89(7): 707 - 709.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online